Clinical Trial

A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection

Name: A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection — clinical trial record (NCT07694557)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Trial Details

NCT Number	NCT07694557
Lead Sponsor	Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Conditions	Respiratory Syncytial Virus (RSV)
Enrollment	180 participants
Start Date	2026-07-15
Primary Completion	2028-07-01 (estimated)
Study Completion	2028-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-10